Cargando…
The gut microbiome and type 2 diabetes status in the Multiethnic Cohort
BACKGROUND: The gut microbiome may play a role in inflammation associated with type 2 diabetes (T2D) development. This cross-sectional study examined its relation with glycemic status within a subset of the Multiethnic Cohort (MEC) and estimated the association of circulating bacterial endotoxin (me...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8221508/ https://www.ncbi.nlm.nih.gov/pubmed/34161346 http://dx.doi.org/10.1371/journal.pone.0250855 |
_version_ | 1783711337985081344 |
---|---|
author | Maskarinec, Gertraud Raquinio, Phyllis Kristal, Bruce S. Setiawan, Veronica W. Wilkens, Lynne R. Franke, Adrian A. Lim, Unhee Le Marchand, Loïc Randolph, Timothy W. Lampe, Johanna W. Hullar, Meredith A. J. |
author_facet | Maskarinec, Gertraud Raquinio, Phyllis Kristal, Bruce S. Setiawan, Veronica W. Wilkens, Lynne R. Franke, Adrian A. Lim, Unhee Le Marchand, Loïc Randolph, Timothy W. Lampe, Johanna W. Hullar, Meredith A. J. |
author_sort | Maskarinec, Gertraud |
collection | PubMed |
description | BACKGROUND: The gut microbiome may play a role in inflammation associated with type 2 diabetes (T2D) development. This cross-sectional study examined its relation with glycemic status within a subset of the Multiethnic Cohort (MEC) and estimated the association of circulating bacterial endotoxin (measured as plasma lipopolysaccharide-binding protein (LBP)) with T2D, which may be mediated by C-reactive protein (CRP). METHODS: In 2013–16, cohort members from five ethnic groups completed clinic visits, questionnaires, and stool and blood collections. Participants with self-reported T2D and/or taking medication were considered T2D cases. Those with fasting glucose >125 and 100–125 mg/dL were classified as undiagnosed (UT2D) and pre-diabetes (PT2D) cases, respectively. We characterized the gut microbiome through 16S rRNA gene sequencing and measured plasma LBP and CRP by standard assays. Linear regression was applied to estimate associations of the gut microbiome community structure and LBP with T2D status adjusting for relevant confounders. RESULTS: Among 1,702 participants (59.9–77.4 years), 735 (43%) were normoglycemic (NG), 506 (30%) PT2D, 154 (9%) UT2D, and 307 (18%) T2D. The Shannon diversity index decreased (p(trend) = 0.05), while endotoxin, measured as LBP, increased (p(trend) = 0.0003) from NG to T2D. Of 10 phyla, Actinobacteria (p(trend) = 0.007), Firmicutes (p(trend) = 0.003), and Synergistetes (p(trend) = 0.02) were inversely associated and Lentisphaerae (p(trend) = 0.01) was positively associated with T2D status. Clostridium sensu stricto 1, Lachnospira, and Peptostreptococcaceae were less, while Escherichia-Shigella and Lachnospiraceae were more abundant among T2D patients, but the associations with Actinobacteria, Clostridium sensu stricto 1, and Escherichia-Shigella may be due metformin use. PT2D/UT2D values were closer to NG than T2D. No indication was detected that CRP mediated the association of LBP with T2D. CONCLUSIONS: T2D but not PT2D/UT2D status was associated with lower abundance of SCFA-producing genera and a higher abundance of gram-negative endotoxin-producing bacteria suggesting that the gut microbiome may contribute to chronic systemic inflammation and T2D through bacterial translocation. |
format | Online Article Text |
id | pubmed-8221508 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-82215082021-07-07 The gut microbiome and type 2 diabetes status in the Multiethnic Cohort Maskarinec, Gertraud Raquinio, Phyllis Kristal, Bruce S. Setiawan, Veronica W. Wilkens, Lynne R. Franke, Adrian A. Lim, Unhee Le Marchand, Loïc Randolph, Timothy W. Lampe, Johanna W. Hullar, Meredith A. J. PLoS One Research Article BACKGROUND: The gut microbiome may play a role in inflammation associated with type 2 diabetes (T2D) development. This cross-sectional study examined its relation with glycemic status within a subset of the Multiethnic Cohort (MEC) and estimated the association of circulating bacterial endotoxin (measured as plasma lipopolysaccharide-binding protein (LBP)) with T2D, which may be mediated by C-reactive protein (CRP). METHODS: In 2013–16, cohort members from five ethnic groups completed clinic visits, questionnaires, and stool and blood collections. Participants with self-reported T2D and/or taking medication were considered T2D cases. Those with fasting glucose >125 and 100–125 mg/dL were classified as undiagnosed (UT2D) and pre-diabetes (PT2D) cases, respectively. We characterized the gut microbiome through 16S rRNA gene sequencing and measured plasma LBP and CRP by standard assays. Linear regression was applied to estimate associations of the gut microbiome community structure and LBP with T2D status adjusting for relevant confounders. RESULTS: Among 1,702 participants (59.9–77.4 years), 735 (43%) were normoglycemic (NG), 506 (30%) PT2D, 154 (9%) UT2D, and 307 (18%) T2D. The Shannon diversity index decreased (p(trend) = 0.05), while endotoxin, measured as LBP, increased (p(trend) = 0.0003) from NG to T2D. Of 10 phyla, Actinobacteria (p(trend) = 0.007), Firmicutes (p(trend) = 0.003), and Synergistetes (p(trend) = 0.02) were inversely associated and Lentisphaerae (p(trend) = 0.01) was positively associated with T2D status. Clostridium sensu stricto 1, Lachnospira, and Peptostreptococcaceae were less, while Escherichia-Shigella and Lachnospiraceae were more abundant among T2D patients, but the associations with Actinobacteria, Clostridium sensu stricto 1, and Escherichia-Shigella may be due metformin use. PT2D/UT2D values were closer to NG than T2D. No indication was detected that CRP mediated the association of LBP with T2D. CONCLUSIONS: T2D but not PT2D/UT2D status was associated with lower abundance of SCFA-producing genera and a higher abundance of gram-negative endotoxin-producing bacteria suggesting that the gut microbiome may contribute to chronic systemic inflammation and T2D through bacterial translocation. Public Library of Science 2021-06-23 /pmc/articles/PMC8221508/ /pubmed/34161346 http://dx.doi.org/10.1371/journal.pone.0250855 Text en © 2021 Maskarinec et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Maskarinec, Gertraud Raquinio, Phyllis Kristal, Bruce S. Setiawan, Veronica W. Wilkens, Lynne R. Franke, Adrian A. Lim, Unhee Le Marchand, Loïc Randolph, Timothy W. Lampe, Johanna W. Hullar, Meredith A. J. The gut microbiome and type 2 diabetes status in the Multiethnic Cohort |
title | The gut microbiome and type 2 diabetes status in the Multiethnic Cohort |
title_full | The gut microbiome and type 2 diabetes status in the Multiethnic Cohort |
title_fullStr | The gut microbiome and type 2 diabetes status in the Multiethnic Cohort |
title_full_unstemmed | The gut microbiome and type 2 diabetes status in the Multiethnic Cohort |
title_short | The gut microbiome and type 2 diabetes status in the Multiethnic Cohort |
title_sort | gut microbiome and type 2 diabetes status in the multiethnic cohort |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8221508/ https://www.ncbi.nlm.nih.gov/pubmed/34161346 http://dx.doi.org/10.1371/journal.pone.0250855 |
work_keys_str_mv | AT maskarinecgertraud thegutmicrobiomeandtype2diabetesstatusinthemultiethniccohort AT raquiniophyllis thegutmicrobiomeandtype2diabetesstatusinthemultiethniccohort AT kristalbruces thegutmicrobiomeandtype2diabetesstatusinthemultiethniccohort AT setiawanveronicaw thegutmicrobiomeandtype2diabetesstatusinthemultiethniccohort AT wilkenslynner thegutmicrobiomeandtype2diabetesstatusinthemultiethniccohort AT frankeadriana thegutmicrobiomeandtype2diabetesstatusinthemultiethniccohort AT limunhee thegutmicrobiomeandtype2diabetesstatusinthemultiethniccohort AT lemarchandloic thegutmicrobiomeandtype2diabetesstatusinthemultiethniccohort AT randolphtimothyw thegutmicrobiomeandtype2diabetesstatusinthemultiethniccohort AT lampejohannaw thegutmicrobiomeandtype2diabetesstatusinthemultiethniccohort AT hullarmeredithaj thegutmicrobiomeandtype2diabetesstatusinthemultiethniccohort AT maskarinecgertraud gutmicrobiomeandtype2diabetesstatusinthemultiethniccohort AT raquiniophyllis gutmicrobiomeandtype2diabetesstatusinthemultiethniccohort AT kristalbruces gutmicrobiomeandtype2diabetesstatusinthemultiethniccohort AT setiawanveronicaw gutmicrobiomeandtype2diabetesstatusinthemultiethniccohort AT wilkenslynner gutmicrobiomeandtype2diabetesstatusinthemultiethniccohort AT frankeadriana gutmicrobiomeandtype2diabetesstatusinthemultiethniccohort AT limunhee gutmicrobiomeandtype2diabetesstatusinthemultiethniccohort AT lemarchandloic gutmicrobiomeandtype2diabetesstatusinthemultiethniccohort AT randolphtimothyw gutmicrobiomeandtype2diabetesstatusinthemultiethniccohort AT lampejohannaw gutmicrobiomeandtype2diabetesstatusinthemultiethniccohort AT hullarmeredithaj gutmicrobiomeandtype2diabetesstatusinthemultiethniccohort |